Stockscreener 앱 받기
5.49
1.86%
0.10
시간 외 거래:
5.38
-0.11
-2.00%
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Serina Therapeutics Files For Mixed Shelf Of Upto $100 MillionSEC Filing - MarketScreener
Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Serina Cuts $11.2M Debt, Secures $10M Investment While Revenue Drops 98% - Stock Titan
Serina Therapeutics to Present Novel Data on Non-Immunogenic Lipid Nanoparticles at ACS Spring 2025 Meeting - Nasdaq
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewswire
Revolutionary Drug Platform Eliminates Major Safety Risk in mRNA Vaccines and Gene Therapies - Stock Titan
Jones Trading Initiates Coverage of Serina Therapeutics (SER) with Buy Recommendation - Nasdaq
Serina Therapeutics initiated with a Buy at JonesResearch - TipRanks
Serina Therapeutics Appoints Dr. Venkatesan to Board - TipRanks
Serina Therapeutics Appoints Dr. Jay Venkatesan to Board of Directors - Nasdaq
Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewswire
Former Alpine Immune Sciences Founder Who Led $4.9B Exit Takes Board Seat at Serina - StockTitan
Huntsville biotech firm partnering with Pfizer lands $10 million for Parkinson’s trial - MSN
Serina secures additional $5 million for Parkinson's trial - MSN
Serina secures additional $5 million for Parkinson's trial By Investing.com - Investing.com Australia
Stocks to Watch: Palantir Technologies, Synaptics, J&J Snack Foods, Serina Therapeutics - MarketWatch
Serina Therapeutics's Shares Up Following $5M of Equity Financing - MarketWatch
Serina Therapeutics Receives Second $5 Mln Tranche To Strengthen Cash Position - Marketscreener.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Serina Therapeutics receives funding to advance SER-252 into clinical trial - TipRanks
Serina Therapeutics Secures $5 Million for SER-252 Trials - TipRanks
Serina Therapeutics Receives Second $5 Million Tranche to - GlobeNewswire
Parkinson's Breakthrough: Serina Therapeutics Lands Premium-Priced $5M Investment to Advance Novel Treatment - StockTitan
Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics - MarketWatch
Serina Therapeutics Shares Rise After Sale of UniverXome Subsidiary - MarketWatch
Serina Therapeutics Sells UniverXome Subsidiary - MarketWatch
Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewswire
Serina Therapeutics Achieves Debt-Free Status After $11.2M UniverXome Sale, Sharpens Focus on Parkinson's Drug - StockTitan
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewswire
Serina Therapeutics, Inc. Appoints Karen J. Wilson to its Board of Directors -January 14, 2025 at 05:25 pm EST - Marketscreener.com
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 By Investing.com - Investing.com Australia
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 - Investing.com
Serina Therapeutics expands equity incentive plan By Investing.com - Investing.com Australia
Serina Therapeutics expands equity incentive plan - Investing.com India
Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - BioSpace
Serina Therapeutics to Present at Tribe Public’s Webinar - GlobeNewswire
Serina Therapeutics to Unveil Breakthrough Parkinson's Treatment Strategy in Upcoming Webinar - StockTitan
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewswire
Serina Therapeutics Unveils Breakthrough LNP Technology: Zero Immune Response in Key Testing - StockTitan
Serina raises $10M to develop SER-252 for advanced Parkinson’s - Parkinson's News Today
Serina Therapeutics Raises $10M in Financing - FinSMEs
Serina Therapeutics, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes - MSN
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Ex - Asianet Newsable
Serina Therapeutics Shares Rise After $10 Million in Financing - MarketWatch
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - The Manila Times
Serina Therapeutics secures $10M financing - TipRanks
Serina Therapeutics Secures $10 Million Financing to - GlobeNewswire
Serina Therapeutics Secures $10M Financing for Parkinson's Drug Trial at 120% Premium - StockTitan
Serina Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - The Manila Times
1.23%
1.63%
자본화:
|
볼륨(24시간):